WHC is still in active development. Read this to understand our approach.
depiction of ZXNRTKGTQJPIJK-UHFFFAOYSA-N.svg
tripsit

aniracetam

Check on tripsit

psychonaut

Aniracetam

Check on psychonaut

isomerdesign

Aniracetam

Check on isomerdesign

druglab

Aniracétam

Check on druglab

drugmap

Aniracetam

Check on drugmap

wiki

Aniracetam

Check on wiki

Data

InChI: InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3

Synonyms: Aniracetam ,(S),BRD-K88611939-001-02-6,Q417630,NCGC00015116-02,aniracetam,NCGC00015116-06, 1-p-Anisoyl-2-pyrrolidinone, 1-(4-methoxybenzoyl)pyrrolidin-2-one, 72432-10-1,CHEBI:47943,Tocris-0867,DTXSID5045128,SDCCGSBI-0050103.P005,HMS3884C09,MFCD00153767,DSSTox_RID_80691,SBI-0050103.P004,NCGC00021402-05,1-p-Anisoyl-2-pyrrolidinone,AC-15651,SR-01000003147-6,SW199095-2,SPECTRUM1503078,A837527,s1281,Spectrum4_000761,NSC758223,BPBio1_001316,NCGC00015116-12,Ampamet,Aniracetam, >=98%,Memodrin,KS-5313,NCGC00260800-01,HMS3675P17,Tox21_110086,Draganon,Lopac-A-9950,Opera_ID_294,KBio2_006958,Aniracetamun [INN-Latin],ANIRACETAM [MI],SR-01000003147-2,SMR000038438,ANIRACETAM [INN],HB0116,Aniracetam p-Methoxybenzoyl-2-pirrolidone,BSPBio_003026,ANIRACETAM; 1-P-ANISOYL-2-PYRROLIDINONE, Sarpul,CHEMBL36994,LP00115,SR-01000003147,BCPP000399, 5L16LKN964, NCGC00015116-10,1-(4-Methoxybenzoyl)pyrrolidin-2-one,MLS000028591,A 9950,Tox21_110086_1,NINDS_000403, 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German],SR-01000003147-8,Spectrum3_001553,Aniracetamun,KBio3_002526,Aniracetam [USAN:INN:JAN],Ro-135057, Ro-13-5057,NSC 758223,NCGC00015116-03,HMS3266L08, 1-(4-Methoxybenzoyl)-2-pyrrolidinone, 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-, Aniracetam [USAN:INN:JAN],Tox21_500115, SMR000038438,BRD-K88611939-001-13-3,EU-0100115, UNII-5L16LKN964,aniracetam;p-methoxybenzoyl-2-pirrolidone,AB00053303_15,2-Pyrrolidinone, 1-(4-methoxybenzoyl)-,1-(4-methoxybenzoyl)pyrrolidin-2-one,Ro-13-3057,GTPL4133, MLS000079240,NCGC00015116-13,HMS501E05,Reset,NSC-758223,DivK1c_000403,NCGC00021402-02,1-p-anisoylpyrrolidin-2-one,NCGC00015116-04,Biomol-NT_000222, CHEBI:47943,SR-01000003147-4,HMS3657G11,1-(p-methoxybenzoyl)-2-pyrrolidinone,HMS2089O17,CAS-72432-10-1, Ro 135057,1-(4-Methoxy-benzoyl)-pyrrolidin-2-one,Spectrum5_001609,UNII-5L16LKN964,HMS3713N20,ZINC15951,Aniracetam,Pharmakon1600-01503078,KBioGR_001142,NCGC00021402-08,KBioSS_001822, CHEMBL36994,432A101,IDI1_000403,NCGC00015116-11,BA164183,DSSTox_CID_25128,ANIRACETAM [MART.],1-(4-Methoxybenzoyl)-2-pyrrolidinone #,BCP02091,HMS3411P17,1-(p-Methoxybenzoyl)-2-pyrrolidinon [German],KBio1_000403,H10883,NCGC00015116-01,AB00053303-14, Draganon,NCGC00015116-08,KBio2_004390,Lopac0_000115,D01883, Ampamet,CS-1793,Ro 13-5057,1-(4-Methoxybenzoyl)-2-pyrrolidone,1-(4-Methoxybenzoyl)-2-pyrrolidinone,BRN 4807205,KBio2_001822,Spectrum_001342,NCGC00021402-07,NCGC00021402-06,DSSTox_GSID_45128,DTXCID3025128,SCHEMBL70998,Sarpul,AB04115,MLS001201800,ANIRACETAM [USAN],5L16LKN964,HMS3260G12,AB00053303_16,MLS000079240,NCGC00015116-05,BCP9000303,NCGC00015116-07,1-anisoyl-2-pyrrolidinone,ANIRACETAM [JAN],Aniracetam (JAN/USAN/INN), ZXNRTKGTQJPIJK-UHFFFAOYSA-N,HMS2234E11,FT-0649064,DB04599,NCGC00015116-09,Ro-13-5057,1-(p-Methoxybenzoyl)-2-pyrrolidinon,NCGC00015116-10,CCG-204210, Aniracetamun [INN-Latin], Ro 13-5057,72432-10-1,AKOS005066313, 1-p-anisoylpyrrolidin-2-one,HMS2094K07,ANIRACETAM [WHO-DD],HY-10932,Ro 135057,1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one, BRN 4807205,NCGC00015116-24

Market name: aniracetam

Estimated data

Solubility: -2.387 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 67.1% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.